PBI is pleased to announce an excellent rate of accrual of advanced pancreatic cancer patients to their Phase II clinical study. PBI is pleased to announce an excellent rate of accrual of advanced pancreatic cancer patients to their Phase II clinical study. PBI is pleased to announce an excellent rate of accrual of advanced pancreatic cancer patients to their Phase II clinical study. [email protected]2023-12-04T17:18:06+00:00 Read More 0
